Crism Therapeutics annual operating margin
2023
2024
2025
Crism Therapeutics Operating Margin Growth & History (CRTX)
Crism Therapeutics's operating margin was −812.99% for fiscal 2025.
View full Crism Therapeutics company overviewCrism Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −812.99% | +2707.01 pp |
| 2024 | 2024-12-31 | −3,520.00% | −3142.22 pp |
| 2023 | 2023-12-31 | −377.78% | — |
Crism Therapeutics operating margin trends
Between the periods ended 2023-12-31 and 2025-12-31, Crism Therapeutics's operating margin decreased from −377.78% to −812.99%, a change of −435.21 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as reported operating income divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Crism Therapeutics source filings ↗Community posts
CRISM reports higher development spending and a £1.41 million loss
CRISM Therapeutics ($CRTX) reported a first-half loss of £1.413 million, compared with £0.930 million a year earlier. Administrative expenses reached £1.52 million, including £956,000 of research and development spending. Operating cash out ...
